+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study



Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study



Journal of Gastroenterology and Hepatology 30(1): 155-162



The hepatotoxicity of statins in patients with chronic liver diseases remains unclear. In this study, we aimed to estimate the risk of severe hepatic injury associated with different statins in patients with chronic liver disease. A nationwide population-based cohort study was conducted by analyzing the Taiwan National Health Insurance database. A total of 37,929 subjects with chronic liver disease who started statin therapy were identified during the period of January 1, 2005 to December 31, 2009. Outcome was defined as hospitalization due to liver injury. During a total of 118,772 person-years of follow-up, 912 incident cases of hospitalization due to hepatic injury are identified. The incidence rate was 2.95, 2.49, 2.92, 1.94, 2.65, and 2.52 per 100,000 person-days for atorvastatin, lovastatin, fluvastatin, pravastatin, simvastatin, and rosuvastatin initiators, respectively. Overall, there was no difference in the incidence associated with different statins. However, when each statin was further categorized to high (โ‰งโ€‰0.5 defined daily dose) or low (<โ€‰0.5 defined daily dose) mean daily dose, only high-dose atorvastatin was significantly associated with increased risk of hospitalization due to hepatic injury (hazard ratio, 1.62; 95% confidence interval, 1.29, 2.03) as compared with low-dose atorvastatin. The overall incidence of hospitalization due to severe hepatic injury was low among statin initiators with chronic liver disease. Only high-dose atorvastatin was associated with increased risk.

(PDF emailed within 0-6 h: $19.90)

Accession: 055739282

Download citation: RISBibTeXText

PMID: 25041076

DOI: 10.1111/jgh.12657


Related references

Risk of empyema in patients with chronic liver disease and cirrhosis: A nationwide, population-based cohort study. Liver International 37(6): 862-870, 2016

Statins and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis: A Danish nationwide population-based cohort study. International Journal of Cancer 2019, 2019

Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. International Journal of Cardiology 196: 91-97, 2016

High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study. Clinical Epidemiology 10: 159-165, 2018

Increased risk of tinnitus in patients with chronic kidney disease: A nationwide, population-based cohort study. Plos One 12(8): E0183192, 2017

Risk of Incident Chronic Kidney Disease and End-Stage Renal Disease in Patients with Psoriasis: a Nationwide Population-Based Cohort Study. Value in Health 18(7): A415, 2015

Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study. Journal of Dermatological Science 78(3): 232-238, 2016

Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study. Plos One 12(10): E0180446, 2017

Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan. Clinical Therapeutics 33(10): 1365-1370, 2012

Risk of Periodontal Diseases in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-based Cohort Study. Medicine 94(46): E2047, 2016

Efficacy of different statins for primary prevention of atrial fibrillation in male and female patients: a nationwide population-based cohort study. International Journal of Cardiology 168(4): 4367-4369, 2014

The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: A nationwide, population-based, cohort study. Journal of Research in Medical Sciences 20(3): 263-267, 2015

Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea. PharmacoTherapy 38(11): 1095-1105, 2018

Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study. Oncotarget 9(26): 18214-18223, 2018

Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study. Plos One 13(11): E0207756, 2018